Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report

BACKGROUND: The treatment of advanced or metastatic renal cell carcinoma (RCC) has drastically changed since the approval of immune checkpoint therapy. Nivolumab is a treatment option for patients with metastatic RCC, previously treated with targeted antiangiogenic therapy. The efficacy of nivolumab...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Urol
Main Authors: Noguchi, Go, Tsutsumi, Sohgo, Yasui, Masato, Ohtake, Shinji, Umemoto, Susumu, Nakaigawa, Noboru, Yao, Masahiro, Kishida, Takeshi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5907256/
https://ncbi.nlm.nih.gov/pubmed/29669553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0339-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki